alexa Targeting Epigenetic Mechanism as the Novel AML Therapy | OMICS International | Abstract
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Targeting Epigenetic Mechanism as the Novel AML Therapy

Yali Dou*

Department of Pathology University of Michigan, USA

*Corresponding Author:
Yali Dou
Department of Pathology University of Michigan, USA
Tel: 734-615-1315
Fax: 734-936-7361
E-mail: [email protected]

Received date: November 27, 2012; Accepted date: November 28, 2012; Published date: November 30, 2012

Citation: Dou Y (2012) Targeting Epigenetic Mechanism as the Novel AML Therapy. J Clin Exp Pathol 2:e116. doi:10.4172/2161-0681.1000e116

Copyright: ©2012 Dou Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Conferences

World Congress on Pathology and Microbiology

Manila, Philippines
Share This Page
Top